logoCabeceraNinos

Hemos leído sobre ... Vasculitis

Última actualización: 16 Octubre 2018
 
 
OCTUBRE 2018
  • Grasa CD, Fernandez-Cooke E, Sánchez-Manubens J, Antón J, Crespo D, García M, López A, Lirola Cruz MJ, Díaz-Delgado de la Peña R, Calvo C; Spanish network for the study of Kawasaki disease, KAWA-RACE.
    Kawasaki disease in infants 3 months of age and younger: a multicentre Spanish study
    Ann Rheum Dis. 2018 Oct 3. pii: annrheumdis-2018-213891. doi: 10.1136/annrheumdis-2018-213891. [Epub ahead of print] No abstract available.
    https://www.ncbi.nlm.nih.gov/pubmed/30282667
  • Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, Barendregt AM, Menikou S, Gormley S, Berk M, Hoang LT, Tremoulet AH, Kanegaye JT, Coin LJM, Glodé MP, Hibberd M, Kuijpers TW, Hoggart CJ, Burns JC, Levin M; Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG).
    Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
    JAMA Pediatr. 2018 Oct 1;172(10):e182293.
    https://www.ncbi.nlm.nih.gov/pubmed/30083721
  • Akamine K, Punaro M.
    Biologics for childhood systemic vasculitis.
    Pediatr Nephrol. 2018 Sep 10. doi: 10.1007/s00467-018-4076-2. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30203375
  • Fabi M, Corinaldesi E, Pierantoni L, Mazzoni E, Landini C, Bigucci B, et al
    Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    PLoS One. 2018 Sep 4;13(9):e0202658.
    https://www.ncbi.nlm.nih.gov/pubmed/30180185.
  • Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, Shimizu C, Sheets R, Tremoulet AH, Burns JC.
    Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.
    J Pediatr. 2018 Sep 26. pii: S0022-3476(18)31089-8. doi: 10.1016/j.jpeds.2018.07.090. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30268398
  • Kwon YC, Kim JJ, Yu JJ, Yun SW, Yoon KL, Lee KY, et al; Korean Kawasaki Disease Genetics Consortium
    Identification of the TIFAB Gene as a Susceptibility Locus for Coronary Artery Aneurysm in Patients with Kawasaki Disease.
    Pediatr Cardiol. 2018 Sep 28. doi: 10.1007/s00246-018-1992-7. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30267110
  • Che D, Pi L, Xu Y, Fu L, Zhou H, Wang Z, Huang P, Zhang L, Gu X.
    TBXA2R rs4523 G allele is associated with decreased susceptibility to Kawasaki disease.
    Cytokine. 2018 Sep 1;111:216-221. doi: 10.1016/j.cyto.2018.08.029. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30179800
  • Yang HF, Fan HC.
    Kawasaki disease shock syndrome and macrophage activation syndrome.
    Paediatr Int Child Health. 2018 Sep 27:1. doi: 10.1080/20469047.2018.1511028. [Epub ahead of print] 

    https://www.ncbi.nlm.nih.gov/pubmed/30257616
  • Wang K, Sun X, Cao Y, Dai L, Sun F, Yu P, Dong L.
    Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study.
    Medicine (Baltimore). 2018 Sep;97(38):e12520.
    https://www.ncbi.nlm.nih.gov/pubmed/30235770
  • Hwang HH, Lim IS, Choi BS, Yi DY.
    Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases.
    Medicine (Baltimore). 2018 Sep;97(36):e12217
    https://www.ncbi.nlm.nih.gov/pubmed/30200139
  • Pepper RJ, McAdoo SP, Moran SM, Kelly D, Scott J, Hamour S, Burns A, Griffith M, Galliford J, Levy JB, Cairns TD, Gopaluni S, Jones RB, Jayne D, Little MA, Pusey CD, Salama AD.
    A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis.
    Rheumatology (Oxford). 2018 Sep 18. doi: 10.1093/rheumatology/key288. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30239910
  • Ismailova DS, Abramova JV, Novikov PI, Grusha YO.
    Clinical features of different orbital manifestations of granulomatosis with polyangiitis.
    Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1751-1756
    https://www.ncbi.nlm.nih.gov/pubmed/29846785
  • Zeiler SR, Qiao Y, Pardo CA, Lim M, Wasserman BA.
    Vessel Wall MRI for Targeting Biopsies of Intracranial Vasculitis.
    AJNR Am J Neuroradiol. 2018 Sep 27. doi: 10.3174/ajnr.A5801. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30262647
  • Kolkhir P, Grakhova M, Bonnekoh H, Krause K, Maurer M.
    Treatment of urticarial vasculitis: A systematic review.
    J Allergy Clin Immunol. 2018 Sep 27. pii: S0091-6749(18)31356-3. doi: 10.1016/j.jaci.2018.09.007. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30268388
 
SEPTIEMBRE 2018
 
AGOSTO 2018
  • Watanabe T.
    Clinical features of acute kidney injury in patients with Kawasaki disease.
    World J Clin Pediatr. 2018 Aug 30;7(3):83-88. doi: 10.5409/wjcp.v7.i3.83.
    https://www.ncbi.nlm.nih.gov/pubmed/30191137
  • Ozeki Y, Yamada F, Saito A, Kishimoto T, Yashiro M, Makino N, Nakamura Y.
    Epidemiologic features of Kawasaki disease distinguished by seasonal variation: an age-specific analysis.
    Ann Epidemiol. 2018 Aug 18. pii: S1047-2797(18)30008-5. doi: 10.1016/j.annepidem.2018.08.004. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30181018
  • Zhou Y, Wang S, Zhao J, Fang P.
    Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease.
    Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5121-5126. doi: 10.26355/eurrev_201808_15706.
    https://www.ncbi.nlm.nih.gov/pubmed/30178831
  • Basha A, Rawat A, Jindal AK, Gupta A, Anand S, Garg R, Minz RW, Singh S.
    Autoantibody profile in children with Kawasaki disease on long-term follow-up: A prospective study from North India.
    Int J Rheum Dis. 2018 Aug 30. doi: 10.1111/1756-185X.13372. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30168280
  • Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Indian J Pediatr. 2018 Aug 30. doi: 10.1007/s12098-018-2765-2. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30159809
  • Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.
    Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.
    Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3.
    https://www.ncbi.nlm.nih.gov/pubmed/30157897
  • Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.
    Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.
    Ital J Pediatr. 2018 Aug 30;44(1):103. doi: 10.1186/s13052-018-0529-2.
    https://www.ncbi.nlm.nih.gov/pubmed/30157893
  • Ozen S, Batu ED.
    Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
    Front Immunol. 2018 Aug 14;9:1892. doi: 10.3389/fimmu.2018.01892.
    https://www.ncbi.nlm.nih.gov/pubmed/30154798
  • Ishikawa T, Nishizawa A, Fujimoto N, Satoh T.
    Kawasaki disease-like symptoms occurring concomitantly with Hodgkin's lymphoma.
    Eur J Dermatol. 2018 Aug 27. doi: 10.1684/ejd.2018.3376. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30147023
  • Okabe M, Hirono K, Tamura K, Ichida F, Kanegane H.
    Reactive peripheral blood plasmacytosis in Kawasaki disease.
    Pediatr Int. 2018 Aug 20. doi: 10.1111/ped.13600. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30125435
  • Che D, Li J, Fu L, Pi L, Rong X, Wang Y, Xu Y, Huang P, Chu M, Gu X.
    The rs1625579 T>G polymorphism in the miRNA-13 gene confers a risk of early- onset Kawasaki disease in a southern Chinese population.
    Infect Drug Resist. 2018 Aug 3;11:1055-1060. doi: 10.2147/IDR.S174140.
    https://www.ncbi.nlm.nih.gov/pubmed/30122962
  • Yang D, Kuang H, Zhou Y, Cai C, Lu T.
    Height, VKORC1 1173, and CYP2C9 Genotypes Determine Warfarin Dose for Pediatric Patients with Kawasaki Disease in Southwest China.
    Pediatr Cardiol. 2018 Aug 18. doi: 10.1007/s00246-018-1957-x. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30121860
  • Muthusami P, Luining W, McCrindle B, van der Geest R, Riesenkampff E, Yoo SJ, Seed M, Manlhiot C, Grosse-Wortmann L.
    Myocardial Perfusion, Fibrosis, and Contractility in Children With Kawasaki Disease.
    JACC Cardiovasc Imaging. 2018 Aug 6. pii: S1936-878X(18)30538-2. doi: 10.1016/j.jcmg.2018.06.009. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30121268
  • Cui J, Zhou Y, Hu H, Zhao L, Du Z, Du H.
    PGK1 as an immune target in Kawasaki disease.
    Clin Exp Immunol. 2018 Aug 16. doi: 10.1111/cei.13204. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30113070
  • Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA.
    Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.
    Arch Dis Child. 2018 Aug 13. pii: archdischild-2018-315087. doi: 10.1136/archdischild-2018-315087. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30104394
  • Cameron SA, Robinson JD, Carr MR, Patel A.
    Giant coronary artery aneurysms in an infant with Kawasaki disease: Evaluation by echocardiography and computed tomographic angiography.
    Echocardiography. 2018 Aug 12. doi: 10.1111/echo.14118. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30099768
  • Hule GP, Kanvinde PR, Kulkarni MA, van Leeuwen K, de Boer M, Bargir UA, Taur PD, Desai MM, Madkaikar MR4.
    p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease.
    J Clin Immunol. 2018 Aug;38(6):638-641. doi: 10.1007/s10875-018-0532-9. Epub 2018 Aug 9.
    https://www.ncbi.nlm.nih.gov/pubmed/30091057
  • Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H, Barendregt AM, Menikou S, Gormley S, Berk M, Hoang LT, Tremoulet AH, Kanegaye JT, Coin LJM, Glodé MP, Hibberd M, Kuijpers TW, Hoggart CJ, Burns JC, Levin M; Immunopathology of Respiratory, Inflammatory and Infectious Disease Study (IRIS) Consortium and the Pediatric Emergency Medicine Kawasaki Disease Research Group (PEMKDRG).
    Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.
    JAMA Pediatr. 2018 Aug 6:e182293. doi: 10.1001/jamapediatrics.2018.2293. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30083721
  • Fernández-Cooke E, Barrios Tascón A, Antón-López J, Grasa Lozano CD, Sánchez-Manubens J, Calvo C; en representación del Grupo de trabajo para el estudio de la enfermedad de Kawasaki (KAWA-RACE).
    Previous or coincident infections with suspected Kawasaki disease. Should we change our approach?
    An Pediatr (Barc). 2018 Aug 1. pii: S1695-4033(18)30308-4. doi: 10.1016/j.anpedi.2018.06.017. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30077502
  • Wang F, Huang L, Tang H, Li X, Zhu X, Wang X.
    Significance of glomerular fibrinogen deposition in children with Henoch-Schönlein purpura nephritis.
    Ital J Pediatr. 2018 Aug 16;44(1):97. doi: 10.1186/s13052-018-0538-1.
    https://www.ncbi.nlm.nih.gov/pubmed/30115075
  • Kisla Ekinci RM, Balcı S, Mart OO, Tumgor G, Yavuz S, Celik H, Dogruel D, Altintas DU5, Yilmaz M.
    Is Henoch-Schönlein purpura a susceptibility factor for functional gastrointestinal disorders in children?
    Rheumatol Int. 2018 Aug 12. doi: 10.1007/s00296-018-4129-7. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30101368
  • Jariwala MP, Laxer RM.
    Primary Vasculitis in Childhood: GPA and MPA in Childhood.
    Front Pediatr. 2018 Aug 16;6:226. doi: 10.3389/fped.2018.00226.
    https://www.ncbi.nlm.nih.gov/pubmed/30167431
  • Uehara E, Nagata C, Masuda H, Fujimori K, Kobayashi S, Kubota M, Ishiguro A.
    Risk factors of long hospital stay for IgA vasculitis: a single center study.
    Pediatr Int. 2018 Aug 21. doi: 10.1111/ped.13685. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30129988
  • Kaspar CDW, Sanderson K, Ozen S, Verghese PS, Lo M, Bunchman TE, Wenderfer SE, Kidd J.
    Pediatric Nephrology and Rheumatology Practice Patterns in Granulomatosis with Polyangiitis: A Midwest Pediatric Nephrology Consortium Study.
    Int J Nephrol. 2018 Aug 5;2018:8413096. doi: 10.1155/2018/8413096.
    https://www.ncbi.nlm.nih.gov/pubmed/30155302
 
JULIO 2018
  • Chbeir D, Gaschignard J, Bonnefoy R, Beyler C, Melki I, Faye A, Meinzer U
    Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions.
    Pediatr Rheumatol Online J. 2018 Jul 18;16(1):48. doi: 10.1186/s12969-018-0264-7.
    https://www.ncbi.nlm.nih.gov/pubmed/30021610
  • Colomba C, La Placa S, Saporito L, Corsello G, Ciccia F, Medaglia A, Romanin B, Serra N, Di Carlo P, Cascio A.
  • Intestinal Involvement in Kawasaki Disease.
    J Pediatr. 2018 Jul 17. pii: S0022-3476(18)30833-3. doi: 10.1016/j.jpeds.2018.06.034. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/30029859
  • Okubo Y, Michihata N, Morisaki N, Sundel RP, Matsui H, Fushimi K, Yasunaga H.
    Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease.
    Arthritis Care Res (Hoboken). 2018 Jul;70(7):1052-1057. doi: 10.1002/acr.23456. Epub 2018 May 22.
    https://www.ncbi.nlm.nih.gov/pubmed/29073349
  • Fina A, Dubus JC, Tran A, Derelle J, Reix P, Fayon M, Couderc L, Donnou MD, Pagnier A, Blanchon S, Faure N, Mely L, Albertini M, de Blic J, Giovannini-Chami L.
    Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort.
    Pediatr Pulmonol. 2018 Jun 26. doi: 10.1002/ppul.24089. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29943913
 
JUNIO 2018
  • Clemente G, Silva CA, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT.
    Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases.
    Rheumatol Int. 2018 Jun;38(6):1089-1094. doi: 10.1007/s00296-018-4030-4
    https://www.ncbi.nlm.nih.gov/pubmed/29687155
  • Kone-Paut I, Cimaz R, Herberg J, Bates O, Carbasse A, Saulnier JP, Maggio MC, Anton J, Piram M.
    The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series.
    Autoimmun Rev. 2018 Jun 6. pii: S1568-9972(18)30135-6. doi: 10.1016/j.autrev.2018.01.024
    https://www.ncbi.nlm.nih.gov/pubmed/29885546
  • Martins A, Conde M, Brito M, Gouveia C.
    Arthritis in Kawasaki disease: A poorly recognised manifestation.
    J Paediatr Child Health. 2018 Jun 26. doi: 10.1111/jpc.14102
    https://www.ncbi.nlm.nih.gov/pubmed/29943869
  • Kuo HC, Guo MM, Lo MH, Hsieh KS, Huang YH.
    Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
    BMC Pediatr. 2018 Jun 22;18(1):200. doi: 10.1186/s12887-018-1180-1
    https://www.ncbi.nlm.nih.gov/pubmed/29933749
  • Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Am J Emerg Med. 2018 Jun 8. pii: S0735-6757(18)30483-2. doi: 10.1016/j.ajem.2018.06.021
    https://www.ncbi.nlm.nih.gov/pubmed/29903669
  • Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, Varela-Ortiz J, Muñoz-Ramírez M, Garrido-García M, Yamazaki-Nakashimada M.
    Kawasaki Disease Shock Syndrome; A Unique and Severe Subtype of Kawasaki Disease.
    Pediatr Int. 2018 Jun 11. doi: 10.1111/ped.13614
    https://www.ncbi.nlm.nih.gov/pubmed/29888440
  • Migally K, Braunlin EA, Zhang L, Binstadt BA.
    Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.
    Pediatr Res. 2018 Jun;83(6):1136-1145. doi: 10.1038/pr.2018.44
    https://www.ncbi.nlm.nih.gov/pubmed/29554081
  • Makino N, Nakamura Y, Yashiro M, Sano T, Ae R, Kosami K, Kojo T, Aoyama Y, Kotani K, Yanagawa H.
    Epidemiological observations of Kawasaki disease in Japan, 2013-2014.
    Pediatr Int. 2018 Jun;60(6):581-587. doi: 10.1111/ped.13544
    https://www.ncbi.nlm.nih.gov/pubmed/29498791
  • Kawai R, Nomura O, Tomobe Y, Morikawa Y, Miyata K, Sakakibara H, Miura M.
    Retrospective observational study indicates that the paediatric assessment triangle may suggest the severity of Kawasaki disease.
    Acta Paediatr. 2018 Jun;107(6):1049-1054. doi: 10.1111/apa.14249
    https://www.ncbi.nlm.nih.gov/pubmed/29385646
  • Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
    The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
    J Microbiol Immunol Infect. 2018 Jun;51(3):321-331. doi: 10.1016/j.jmii.2017.08.012
    https://www.ncbi.nlm.nih.gov/pubmed/28927685
 
MAYO 2018
  • Bijnens J, Missiaen L, Bultynck G, Parys JB.
    A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease.
    Cell Calcium. 2018 May;71:95-103. doi: 10.1016/j.ceca.2018.01.002. Epub 2018 Feb 3.
    https://www.ncbi.nlm.nih.gov/pubmed/29604968
  • Zhang XY, Yang TT, Hu XF, Wen Y, Fang F, Lu HL.
    Circulating adipokines are associated with Kawasaki disease.
    Pediatr Rheumatol Online J. 2018 May 8;16(1):33. doi: 10.1186/s12969-018-0243-z.
    https://www.ncbi.nlm.nih.gov/pubmed/29739418
  • Choi JE, Kwak Y, Huh JW, Yoo ES, Ryu KH, Sohn S, Hong YM.
    Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.
    Korean J Pediatr. 2018 May;61(5):167-173. doi: 10.3345/kjp.2018.61.5.167. Epub 2018 May 28.
    https://www.ncbi.nlm.nih.gov/pubmed/29853942
  • Seo YM, Kang HM, Lee SC, Yu JW, Kil HR, Rhim JW, Han JW, Lee KY.
    Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment.
    Korean J Pediatr. 2018 May;61(5):160-166. doi: 10.3345/kjp.2018.61.5.160. Epub 2018 May 28.
    https://www.ncbi.nlm.nih.gov/pubmed/29853941
  • Riancho-Zarrabeitia L, Rasilla DF, Royé D, Fdez-Arroyabe P, Santurtún A.
    Kawasaki disease in Spanish paediatric population and synoptic weather types: an observational study.
    Rheumatol Int. 2018 May 30. doi: 10.1007/s00296-018-4066-5. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29846788
  • Grotenhuis HB, Aeschlimann FA, Hui W, Slorach C, Yeung RSM, Benseler SM, Bradley TJ, Grosse-Wortmann L.
    Increased Arterial Stiffness in a Cohort of Pediatric Takayasu Arteritis Patients in Toronto Adversely Affects Left Ventricular Mechanics.
    J Clin Rheumatol. 2018 May 19. doi: 10.1097/RHU.0000000000000824. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29782425
 
ABRIL 2018
  • Wei-Te Lei, Po-Li Tsai, Szu-Hung Chu, Yu-Hsuan Kao, Chien-Yu Lin, Li-Ching Fang, Shyh-Dar Shyur,Yu-Wen Lin, and Shu-I Wu
    Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database
    Pediatr Rheumatol Online J. 2018; 16: 25. Published online 2018 Apr 16. doi:  10.1186/s12969-018-02478
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902957
  • Wang JC, Leader BA, Crane RA, Koch BL, Smith MM, Ishman SL.
    Granulomatosis with polyangiitis presenting as facial nerve palsy in a teenager.
    Int J Pediatr Otorhinolaryngol. 2018 Apr;107:160-163. doi: 10.1016/j.ijporl.2018.02.009. Epub 2018 Feb 7.
    https://www.ncbi.nlm.nih.gov/pubmed/29501300
  • Mangodt TC, Joos R, Siozopoulou V, Cortoos PJ, Baeten H, Docx M, van den Akker M.
    Perinuclear antineutrophil cytoplasmic antibody-positive vasculitis, oligoarthritis, tendinitis, and myositis associated with isotretinoin in a 15-year-old boy: Case report and review of literature.
    Pediatr Dermatol. 2018 Apr 11. doi: 10.1111/pde.13445. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29644707
  • Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, Hong Y, Klein N, Brogan PA.
    Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.
    Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.
    https://www.ncbi.nlm.nih.gov/pubmed/29696024ç
  • Clemente G, Silva CA, Sacchetti SB, Ferriani VPL, Oliveira SK, Sztajnbok F, Bica BERG, Cavalcanti A, Robazzi T, Bandeira M, Terreri MT.
    Takayasu arteritis in childhood: misdiagnoses at disease onset and associated diseases.
    Rheumatol Int. 2018 Apr 23. doi: 10.1007/s00296-018-4030-4. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29687155
  • González-Gay MA, López-Mejías R, Pina T, Blanco R, Castañeda S.
    IgA Vasculitis: Genetics and Clinical and Therapeutic Management.
    Curr Rheumatol Rep. 2018 Apr 2;20(5):24. doi: 10.1007/s11926-018-0735-3.
    https://www.ncbi.nlm.nih.gov/pubmed/29611051
  • Bijnens J, Missiaen L, Bultynck G, Parys JB.
    A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease.
    Cell Calcium. 2018 May;71:95-103. doi: 10.1016/j.ceca.2018.01.002. Epub 2018 Feb 3.
    https://www.ncbi.nlm.nih.gov/pubmed/29604968
  • Şanlidag B, Balkan C, Bahçeciler N.
    A case report: incomplete Kawasaki disease in a hypogammaglobulinémie child.
    Arch Argent Pediatr. 2018 Apr 1;116(2):e322-e324. doi: 10.5546/aap.2018.eng.e322.
    https://www.ncbi.nlm.nih.gov/pubmed/29557626
  • Huang YH, Kuo HC, Li SC, Cai XY, Liu SF, Kuo HC.
    HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
    J Mol Cell Cardiol. 2018 Apr;117:82-87. doi: 10.1016/j.yjmcc.2018.02.017. Epub 2018 Mar 2.
    https://www.ncbi.nlm.nih.gov/pubmed/29501389
  • Guillaume MP, Reumaux H, Dubos F.
    Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm.
    Cardiol Young. 2018 May;28(5):739-742. doi: 10.1017/S1047951117002864. Epub 2018 Feb 19.
    https://www.ncbi.nlm.nih.gov/pubmed/29455693
 
MARZO 2018
  • Clark DE, Denby KJ, Kaufman LM, Fill MA, Piya B, Krishnaswami S, Fonnesbeck C, Halasa N
    Predictors of Intravenous Immunoglobulin Non-Response and Racial Disparities in Kawasaki Disease.
    Pediatr Infect Dis J. 2018 Mar 19. doi: 10.1097/INF.0000000000002019. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29570178
  • Migally K, Braunlin EA, Zhang L, Binstadt BA.
    Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in kawasaki disease.
    Pediatr Res. 2018 Mar 19. doi: 10.1038/pr.2018.44. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29554081
  • Zhang DF, Hao GX, Li CZ, Yang YJ, Liu FJ, Liu L, Yuan XY, Li RH, Dong L, Dong Q, Jacqz-Aigrain E, Zhao W.
    Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study.
    Arch Dis Child. 2018 Mar 13. pii: archdischild-2017-313788. doi: 10.1136/archdischild-2017-313788. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29535109
  • Frantellizzi V, Morreale M, Pontico M, Francia A, Drudi FM, Farcomeni A, Liberatore M
    99mTc-HMPAO SPECT cerebral en la monitorización de la terapia de vasculitis
    Rev Esp Med Nucl Imagen Mol. 2018 Mar 28. pii: S2253-654X(17)30127-0. doi: 10.1016/j.remn.2017.10.009. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/29605630
  • Berti A, Matteson EL, Crowson CS, Specks U, Cornec D.
    Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.
    Mayo Clin Proc. 2018 Mar 24. pii: S0025-6196(18)30109-5. doi: 10.1016/j.mayocp.2018.02.010. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29588079
  • Prendecki M, Martin L, Tanna A, Antonelou M, Pusey CD.
    Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170661. doi: 10.3899/jrheum.170661. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29545453
  • Onuora S.
    Vasculitis: New insights into risk factors for GPA.
    Nat Rev Rheumatol. 2018 Mar 15. doi: 10.1038/nrrheum.2018.44. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29540845
 
FEBRERO 2018
  • Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J. 2018 Feb 15. doi: 10.1097/INF.0000000000001951.
    Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children with Kawasaki Disease Presenting with Coronary Artery Lesions: Is Dual Therapy More Effective?
    https://www.ncbi.nlm.nih.gov/pubmed/29461447
 
ENERO 2018
  • Kawai R, Nomura O, Tomobe Y, Morikawa Y, Miyata K, Sakakibara H, Miura M.
    Retrospective observational study indicates that the Pediatric Assessment Triangle may suggest the severity of Kawasaki disease.
    Acta Paediatr. 2018 Jan 31. doi: 10.1111/apa.14249. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29385646
 
DICIEMBRE 2017
  • Li J, Li H, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X.
    Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis.
    J Rheumatol. 2017 Dec;44(12):1867-1874.
    https://www.ncbi.nlm.nih.gov/pubmed/28811356
  • Kamiyama H, Ayusawa M, Ogawa S, Saji T, Hamaoka K.
    Transition in Patients With Coronary Artery Lesions After Kawasaki Disease.
    Pediatr Int. 2017 Dec 31. doi: 10.1111/ped.13500. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29290099
  • Huang X, Huang P, Zhang L, Xie X, Xia S, Gong F, Yuan J, Jin L.
    Is aspirin necessary in the acute phase of Kawasaki disease?
    J Paediatr Child Health. 2017 Dec 22. doi: 10.1111/jpc.13816. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29271519
  • Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J.
    Aspirin dose in Kawasaki disease - the ongoing battle.
    Arthritis Care Res (Hoboken). 2017 Dec 29. doi: 10.1002/acr.23504. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/29287309
 
NOVIEMBRE 2017
 
OCTUBRE 2017
      • Crnogorac M, Horvatic I, Kacinari P, Ljubanovic DG, Galesic K.
        Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.
        J Nephrol. 2017 Oct 13. doi: 10.1007/s40620-017-0445-3. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29027625
      • Liu Y, Zhu J, Lai JM, Sun XF, Hou J, Zhou ZX, Yuan XY.
        Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous.
        Clin Rheumatol. 2017 Oct 10. doi: 10.1007/s10067-017-3841-0. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/29019060
      • Hennies I, Gimpel C, Gellermann J, Möller K, Mayer B, Dittrich K, Büscher AK, Hansen M, Aulbert W, Wühl E, Nissel R, Schalk G, Weber LT, Pohl M, Wygoda S, Beetz R, Klaus G, Fehrenbach H, König S, Staude H, Beringer O, Bald M, Walden U, von Schnakenburg C, Bertram G, Wallot M, Häffner K, Wiech T, Hoyer PF, Pohl M; German Society of Pediatric Nephrology.
        Presentation of pediatric Henoch-Schönlein purpura nephritis changes with age and renal histology depends on biopsy timing.
        Pediatr Nephrol. 2017 Oct 5. doi: 10.1007/s00467-017-3794-1. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28983704
      • Ohtomo R, Suzuki Y, Maeda N, Kawakami S, Yamada M, Iwata A, Nakase H.
        Successful treatment of recurrent primary CNS vasculitis with etanercept.
        J Neurol Sci. 2017 Oct 15;381:200-202. doi: 10.1016/j.jns.2017.08.3257. Epub 2017.
        https://www.ncbi.nlm.nih.gov/pubmed/28991681
      • Portman MA, Shrestha S.
        One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.
        Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001917. doi: 10.1161/CIRCGENETICS.117.001917.
        https://www.ncbi.nlm.nih.gov/pubmed/29025763
      • Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
        Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
        PLoS One. 2017 Oct 10;12(10):e0185880. doi: 10.1371/journal.pone.0185880.
        https://www.ncbi.nlm.nih.gov/pubmed/29016646
      • Tremoulet AH.
        Adjunctive therapies in Kawasaki disease
        Int J Rheum Dis. 2017 Oct 27. doi: 10.1111/1756-185X.13208. [Epub ahead of print]
        https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29076637
      • Okubo Y, Michihata N, Morisaki N, Sundel RP, Matsui H, Fushimi K, Yasunaga H.
        Association between dose of glucocorticoids and coronary artery lesions in Kawasaki disease
        Arthritis Care Res (Hoboken). 2017 Oct 26. doi: 10.1002/acr.23456. [Epub ahead of print]
        https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29073349
      • Lee KH, Park JH, Kim DH, Hwang J, Lee G, Hyun JS, Heo ST, Choi JH, Kim M, Kim M, Kim SI, Eisenhut M, Kronbichler A, Shin JI.
        Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP)
        Med Hypotheses. 2017 Oct;108:42-45. doi: 10.1016/j.mehy.2017.07.018. Epub 2017 Jul 17.
        https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29055398
      • Heineke MH, Ballering AV, Jamin A, Mkaddem SB, Monteiro RC, Van Egmond M.
        New Insights in the Pathogenesis of Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura).
        Autoimmun Rev. 2017 Oct 13. pii: S1568-9972(17)30259-8. doi: 10.1016/j.autrev.2017.10.009. [Epub ahead of print] Review.
        https://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/29037908
 
SEPTIEMBRE 2017
      • Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, Hellmich B, Jayne D, Jennette JC, Kallenberg CGM, Moiseev S, Novikov P, Radice A, Savige JA, Sinico RA, Specks U, van Paassen P, Zhao MH, Rasmussen N, Damoiseaux J, Csernok E.
        Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.
        Nat Rev Rheumatol. 2017 Sep 14. doi: 10.1038/nrrheum.2017.140. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28905856
      • Frumholtz L, Laurent-Roussel S, Aumaître O, Maurier F, Le Guenno G, Carlotti A, Dallot A, Kemeny JL, Antunes L, Froment N, Fraitag S, London J, Berezne A, Terris B, Le Jeunne C, Mouthon L, Aractingi S, Guillevin L, Dupin N, Terrier B; French Vasculitis Study Group.
        Clinical and pathological significance of cutaneous manifestations in ANCA-associated vasculitides
        Autoimmun Rev. 2017 Sep 14. pii: S1568-9972(17)30233-1. doi: 10.1016/j.autrev.2017.09.009. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28918161
      • Berti A, Cornec D, Crowson CS, Specks U, Matteson EL.
        The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study.
        Arthritis Rheumatol. 2017 Sep 7. doi: 10.1002/art.40313. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28881446
      • Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY.
        The prevention of coronary arterial abnormalities in Kawasaki disease: A meta-analysis of the corticosteroid effectiveness.
        J Microbiol Immunol Infect. 2017 Sep 6. pii: S1684-1182(17)30195-0. doi: 10.1016/j.jmii.2017.08.012. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28927685
      • Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.
        A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.
        Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.
        https://www.ncbi.nlm.nih.gov/pubmed/28874185
      • Coit P, Direskeneli H, Sawalha AH.
        An update on the role of epigenetics in systemic vasculitis.
        Curr Opin Rheumatol. 2017 Sep 27. doi: 10.1097/BOR.0000000000000451. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28957963
      • Lopalco G, Fabiani C, Venerito V, Lapadula G, Iannone F, Cantarini L.
        Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.
        Clin Exp Rheumatol. 2017 Sep 7. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28980903
      • Singh S, Gupta A, Jindal AK, Gupta A, Suri D, Rawat A, Vaidya PC, Singh M.
        Pulmonary presentation of Kawasaki disease-A diagnostic challenge.
        Pediatr Pulmonol. 2017 Sep 26. doi: 10.1002/ppul.23885. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28950425
 
AGOSTO 2017
      • Kim JJ, Yun SW, Yu JJ, Yoon KL, Lee KY, Kil HR, Kim GB, Han MK, Song MS, Lee HD, Ha KS, Sohn S, Johnson TA, Takahashi A, Kubo M, Tsunoda T, Ito K, Onouchi Y, Hong YM, Jang GY, Lee JK; Korean Kawasaki Disease Genetics Consortium.
        A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
        J Hum Genet. 2017 Aug 31. doi: 10.1038/jhg.2017.87. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28855716
      • Lava SAG, Milani GP, Fossali EF, Simonetti GD, Agostoni C, Bianchetti MG.
        Cutaneous Manifestations of Small-Vessel Leukocytoclastic Vasculitides in Childhood.
        Clin Rev Allergy Immunol. 2017 Aug 24. doi: 10.1007/s12016-017-8626-3. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28836099
      • Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.
        Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
        Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.
        https://www.ncbi.nlm.nih.gov/pubmed/28784150
 
JULIO 2017
      • Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.
        Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
        Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.
        https://www.ncbi.nlm.nih.gov/pubmed/28784150
      • Piram M, Maldini C, Biscardi S, De Suremain N, Orzechowski C, Georget E, Regnard D, Koné-Paut I, Mahr A.
        Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study.
        Rheumatology (Oxford). 2017 Apr 24. doi: 10.1093/rheumatology/kex158. [Epub ahead of print]
        https://www.ncbi.nlm.nih.gov/pubmed/28444335
 
JUNIO 2017
      • van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.
        Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
        Ann Rheum Dis. 2017 Jun;76(6):1064-1069
        https://www.ncbi.nlm.nih.gov/pubmed/27899372
      • Alibaz-Oner F, Koster MJ, Crowson CS, Makol A, Ytterberg SR, Salvarani C, Matteson EL, Warrington KJ.
        Clinical Spectrum of Medium-Sized Vessel Vasculitis.
        Arthritis Care Res (Hoboken). 2017 Jun;69(6):884-891
        https://www.ncbi.nlm.nih.gov/pubmed/27564269
      • Álvarez EP, Rey F, Peña SC, Rubio A, Calvo C, Collado P.
        Has joint involvement lessened in Kawasaki disease?
        Reumatol Clin. 2017 May - Jun;13(3):145-149.
        https://www.ncbi.nlm.nih.gov/pubmed/27263965
      • Erden A, Batu ED, Sönmez HE, Sarı A, Armagan B, Arıcı ZS, Bilgin E, Kalyoncu U, Karadağ Ö, Bilginer Y, Ertenli AI, Özen S.
        Comparing polyarteritis nodosa in children and adults: a single center study.
        Int J Rheum Dis. 2017 Jun 19 doi: 10.1111/1756-185X.13120.
        https://www.ncbi.nlm.nih.gov/pubmed/28626961
      • Ozen S, Acar-Ozen NP.
        Recent advances in childhood vasculitis.
        Curr Opin Rheumatol. 2017 Jun 2 doi: 10.1097/BOR.0000000000000424.
        https://www.ncbi.nlm.nih.gov/pubmed/28582318
 
MAYO 2017
      • Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RSM, Toth MB, Shenoi S, Ristic G, Nielson SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; for ARChiVe Investigators Network within the PedVas Initiative.
        Early Outcomes in Children with Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV).
        Arthritis Rheumatol. 2017 Mar 28. doi: 10.1002/art.40112. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28371513
      • Li J, Sun F, Chen Z, Yang Y, Zhao J, Li M, Tian X, Zeng X
        The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years.
        Arthritis Res Ther. 2017 May 25;19(1):107. doi: 10.1186/s13075-017-1307-z.
        https://www.ncbi.nlm.nih.gov/pubmed/28545566
      • Gudbrandsson B, Molberg Ø, Palm Ø.
        TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
        Arthritis Res Ther. 2017 May 18;19(1):99. doi: 10.1186/s13075-017-1316-y.
        https://www.ncbi.nlm.nih.gov/pubmed/?term=28521841
      • Ozen S, Acar-Ozen NP.
        Recent advances in childhood vasculitis.
        Curr Opin Rheumatol. 2017 Jun 2. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28582318
      • Dikkes A, Aschwanden M, Imfeld S, Glatz K, Messerli J, Staub D, Daikeler T.
        Takayasu arteritis: active or not, that's the question.
        Rheumatology (Oxford). 2017 Jun 7. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28595278
 
ABRIL 2017
      • Valenti S, Gallizzi R, De Vivo D, Romano C.
        Intestinal Behçet and Crohn's disease: two sides of the same coin
        Pediatr Rheumatol Online J. 2017 Apr 20;15(1):33. doi: 10.1186/s12969-017-0162-4. Review.
        https://www.ncbi.nlm.nih.gov/pubmed/28427473
      • Morishita KA, Moorthy LN, Lubieniecka JM, Twilt M, Yeung RS, Toth MB, Shenoi S, Ristic G, Nielson SM, Luqmani RA, Li SC, Lee T, Lawson EF, Kostik MM, Klein-Gitelman M, Huber AM, Hersh AO, Foell D, Elder ME, Eberhard BA, Dancey P, Charuvanij S, Benseler SM, Cabral DA; for ARChiVe Investigators Network within the PedVas Initiative.
        Early Outcomes in Children with Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
        Arthritis Rheumatol. 2017 Mar 28. doi: 10.1002/art.40112. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28371513
 
MARZO 2017
      • Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S et al for the Vasculitis Clinical Research Consortium
        A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis
        Arthritis Rheumatol 2017 Apr;69(4):846-53  DOI: 10.1002/art.40037.
        http://onlinelibrary.wiley.com/doi/10.1002/art.40037/full
      • Vijayvergiya R, Bhattad S, Varma S, Singhal M, Gordon J, Singh S.
        Presentation of missed childhood Kawasaki disease in adults: Experience from a tertiary care center in north India
        Int J Rheum Dis 5 Apr 2017 DOI: 10.1111/1756-185X.13073 [Epub ahead of print] http://onlinelibrary.wiley.com/doi/10.1111/1756-185X.13073/abstract
      • Sánchez-Manubens J, Gelman A, Franch N, Teodoro S, Palacios JR, Rudi N, Rivera J, Antón J.
        A child with resistant Kawasaki disease successfully treated with anakinra: a case report.
        BMC Pediatr. 2017 Apr 8;17(1):102. doi: 10.1186/s12887-017-0852-6.
        https://www.ncbi.nlm.nih.gov/pubmed/28390409
FEBRERO 2017
      • McCrindle BW, Selamet Tierney ES.
        Acute Treatment for Kawasaki Disease: Challenges for Current and Future Therapies.
        J Pediatr. 2017 Feb 20. pii: S0022-3476(17)30182-8. doi: 10.1016/j.jpeds.2017.01.072. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/28233548
      • Ramelli V, Lava SA, Simonetti GD, Bianchetti MG, Ramelli GP, Milani GP.
        Blistering eruptions in childhood Henoch-Schönlein syndrome: systematic review of the literature.
        Eur J Pediatr. 2017 Feb 4. doi: 10.1007/s00431-017-2858-3. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28161822
      • Delbet JD, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschênes G, Ulinski T.
        Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
        Pediatr Nephrol. 2017 Feb 15. doi: 10.1007/s00467-017-3604-9. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28204946
      • Dos Santos D, Langer FW, Dos Santos T, Rafael Tronco Alves G, Feiten M, Teixeira de Paula Neto W.
        Posterior reversible encephalopathy syndrome as a complication of Henoch-Schönlein purpura in a seven-year-old girl.
        Scott Med J. 2017 Feb;62(1):34-37. doi: 10.1177/0036933017690467. Epub 2017 Feb 2.
        https://www.ncbi.nlm.nih.gov/pubmed/28152662
ENERO 2017
      • Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.
        Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease.
        Arthritis Rheumatol. 2017 Feb;69(2):268-276. doi: 10.1002/art.39975.
        https://www.ncbi.nlm.nih.gov/pubmed/27792871
      • Amarilyo G, Koren Y, Brik Simon D, Bar-Meir M, Bahat H, Helou MH, Mendelson A, Hezkelo N, Chodick G, Berkun Y, Eisenstein E, Butbul Aviel Y, Barkai G, Bolkier Y, Padeh S, Brik R, Hashkes PJ, Harel L, Uziel Y.
        High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
        Clin Exp Rheumatol. 2017 Jan 5. [Epub ahead of print]https://www.ncbi.nlm.nih.gov/pubmed/28079513
      • Butbul Aviel Y, Dafna L, Pilar G, Brik R.
        Endothelial function in children with a history of henoch schonlein purpura.
        Pediatr Rheumatol Online J. 2017 Jan 14;15(1):3. doi: 10.1186/s12969-016-0135-z.
        https://www.ncbi.nlm.nih.gov/pubmed/28088210
DICIEMBRE 2016
      • Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP.
        National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
        Clin Rheumatol. 2016 Dec 16
        https://www.ncbi.nlm.nih.gov/pubmed/27987089
 
NOVIEMBRE 2016
      • van Daalen EE, Rizzo R, Kronbichler A, Wolterbeek R, Bruijn JA, Jayne DR, Bajema IM, Rahmattulla C.
        Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
        Ann Rheum Dis. 2016 Nov 29.
        https://www.ncbi.nlm.nih.gov/pubmed/27899372
      • Gudbrandsson B, Wallenius M, Garen T, Henriksen T, Molberg Ø, Palm Ø.
        Takayasu arteritis and pregnancy; - a population based study on outcome and mother-child related concerns.
        Arthritis Care Res (Hoboken). 2016 Nov 3
        https://www.ncbi.nlm.nih.gov/pubmed/27813289
      • James KE, Xiao R, Merkel PA, Weiss PF.
        Variation in treatment of children hospitalized with antineutrophil cytoplasmic antibody-associated vasculitis in the United States.
        Arthritis Care Res (Hoboken). 2016 Nov 3.
        https://www.ncbi.nlm.nih.gov/pubmed/27813340
 
OCTUBRE 2016
      • Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative.
        Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study
        Arthritis Rheumatol. 2016 Oct;68(10):2514-26.
        https://www.ncbi.nlm.nih.gov/pubmed/27111558
      • Giménez-Roca C, Iglesias E, Vicente MA, Bou R, Calzada-Hernández J, Prat C, García M, Antón J.
        Pediatric cryoglobulinemic vasculitis successfully managed with rituximab.
        Dermatol Ther. 2016 Oct 28
        https://www.ncbi.nlm.nih.gov/pubmed/27791307
      • Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.
        Paediatric Behçet's disease: a UK tertiary centre experience
        Clin Rheumatol. 2016 Oct;35(10):2509-16
        https://www.ncbi.nlm.nih.gov/pubmed/26833394
      • Burns JC, Koné-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M.
        Found in Translation: International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease
        Arthritis Rheumatol. 2016 Oct 28.
        https://www.ncbi.nlm.nih.gov/pubmed/27792871
 
SEPTIEMBRE 2016
 
AGOSTO 2016
 
JULIO 2016
      • Nakagomi D, Jayne D.
        Outcome assessment in Takayasu arteritis.
        Rheumatology (Oxford). 2016 Jul;55(7):1159-71. doi: 10.1093/rheumatology/kev366. Epub 2015 Oct 15.
        http://www.ncbi.nlm.nih.gov/pubmed/26472566
      • Eleftheriou D, Gale H, Pilkington C, Fenton M, Sebire NJ, Brogan PA.
        Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK.
        Rheumatology (Oxford). 2016 Jul;55(7):1263-72. doi: 10.1093/rheumatology/kew029. Epub 2016 Mar 29.
        http://www.ncbi.nlm.nih.gov/pubmed/27026726 
      • Calvo-Río V, Hernández JL, Ortiz-Sanjuán F, Loricera J, Palmou-Fontana N, González-Vela MC, González-Lamuño D, González-López MA, Armesto S, Blanco R, González-Gay MA.
        Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center.
        Medicine (Baltimore). 2016 Jul;95(28):e4217. doi: 10.1097/MD.0000000000004217.
        http://www.ncbi.nlm.nih.gov/pubmed/27428226
 
JUNIO 2016
      • Fotis L, Tuttle PV 4th, Baszis KW, Pepmueller PH, Moore TL, White AJ.
        Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases.
        Pediatr Rheumatol Online J. 2016 Jun 23;14(1):37. doi: 10.1186/s12969-016-0100-x
        http://www.ncbi.nlm.nih.gov/pubmed/27333803
      • Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L.
        Management of Small Vessel Vasculitides.
        Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Review.
        http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27118389
      • Loricera J, Blanco R, Hernández JL, Castañeda S, Humbría A, Ortego N, Bravo B, Freire M, Melchor S, Mínguez M, Salvatierra J, González-Vela C, Calvo-Río V, Santos-Gómez M, Pina T, González-Gay MA.
        Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
        Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):44-53
        http://www.ncbi.nlm.nih.gov/pubmed/27050507
 
MAYO 2016
 
ABRIL 2016
      • Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L.
        Management of Small Vessel Vasculitides.
        Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Review.
        http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27118389
      • Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins G, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik M, Lawson E, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater H, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas initiative.
        Comparing presenting clinical features of 48 children with microscopic polyangiitis (MPA) against 183 having granulomatosis with polyangiitis (GPA). An ARChiVe study.
        Arthritis Rheumatol. 2016 Apr 25. doi: 10.1002/art.39729
        http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27111558
      • Mauro A, Fabi M, Da Frè M, Guastaroba P, Corinaldesi E, Calabri GB, Giani T, Simonini G, Rusconi F, Cimaz R.
        Kawasaki disease: an epidemiological study in central Italy.
        Pediatr Rheumatol Online J. 2016 Apr 12;14(1):22. doi: 10.1186/s12969-016-0084-6.
        http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27068134
      • Eleftheriou D, Brogan PA.
        Therapeutic advances in the treatment of vasculitis.
        Pediatr Rheumatol Online J. 2016 Apr 26;14(1):26. doi: 10.1186/s12969-016-0082-8. Review.
        http://www-ncbi-nlm-nih-gov.sire.ub.edu/pubmed/27112923
 
MARZO 2016
      • Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J; and the Kawasaki Disease in Catalonia Working Group.
        Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain.
        Clin Exp Rheumatol. 2016 Mar 3. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26939753
      • Han SB, Lee SY, Jeong DC, Kang JH.
        Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
        Ann Rheum Dis. 2016 Mar 10. pii: annrheumdis-2016-209395. doi: 10.1136/annrheumdis-2016-209395.
        http://www.ncbi.nlm.nih.gov/pubmed/26965982
      • Aggarwal V, Etinger V, Orjuela AF.
        Sensorineural hearing loss in Kawasaki disease.
        Ann Pediatr Cardiol. 2016 Jan-Apr;9(1):87-9. doi: 10.4103/0974-2069.171396.
        http://www.ncbi.nlm.nih.gov/pubmed/27011703
      • Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA.
        Paediatric Behçet's disease: a UK tertiary centre experience.
        Clin Rheumatol. 2016 Feb 1. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26833394
 
FEBRERO 2016
      • Hoyos-Bachiloglu R, García Á, Morales PS, Cerda J, Talesnik E, Borzutzky A.
        Geographic distribution of Kawasaki disease throughout Chile
        Rev Chilena Infectol. 2016 Feb;33(1):12-8. doi: 10.4067/S0716-10182016000100002.
        http://www.ncbi.nlm.nih.gov/pubmed/26965872
      • Baek JY, Song MS.
        Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
        Korean J Pediatr. 2016 Feb;59(2):80-90. doi: 10.3345/kjp.2016.59.2.80. Epub 2016 Feb 29.
        http://www.ncbi.nlm.nih.gov/pubmed/26958067
      • Kim JO, Kim YH, Hyun MC.
        Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy.
        Korean J Pediatr. 2016 Feb;59(2):54-8. doi: 10.3345/kjp.2016.59.2.54. Epub 2016 Feb 29.
        http://www.ncbi.nlm.nih.gov/pubmed/26958063
      • Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S.
        Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.
        Int J Mol Sci. 2016 Feb 24;17(3). pii: E278. doi: 10.3390/ijms17030278.
        http://www.ncbi.nlm.nih.gov/pubmed/26927060
      • Kuramitsu S, Hiromasa T, Jinnouchi H, Domei T, Shirai S, Ando K.
        Usefulness of rotational atherectomy with optical frequency domain imaging guidance for severe calcified coronary lesions after Kawasaki disease.
        Cardiovasc Interv Ther. 2016 Feb 26. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26920894
      • Hall GC, Tulloh LE, Tulloh RM.
        Kawasaki disease incidence in children and adolescents an observational study in primary care.
        Br J Gen Pract. 2016 Feb 23. pii: bjgpapr-2016-66-645-hall-fl-p. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26906631
      • Singh S, Kawasaki T.
        Kawasaki Disease in India, Lessons Learnt Over the Last 20 Years.
        Indian Pediatr. 2016 Feb 8;53(2):119-24.
        http://www.ncbi.nlm.nih.gov/pubmed/26897142
      • Tang Y, Gao X, Shen J, Sun L, Yan W.
        Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience.
        J Trop Pediatr. 2016 Feb 15. pii: fmv077. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26884440
      • Chen KY, Curtis N, Dahdah N, Kowalski R, Cheung M, Burgner DP.
        Kawasaki Disease and Cardiovascular Risk: A Comprehensive Review of Subclinical Vascular Changes in the Longer Term.
        Acta Paediatr. 2016 Feb 16. doi: 10.1111/apa.13367. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26880292
      • Li Z, Tan Z, Hao S, Jin B, Deng X, Hu G, Liu X, Zhang J, Jin H, Huang M, Kanegaye JT, Tremoulet AH, Burns JC, Wu J, Cohen HJ, Ling XB; Emergency Medicine Kawasaki Disease Research Group.
        Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses.
        PLoS One. 2016 Feb 9;11(2):e0146733. doi: 10.1371/journal.pone.0146733. eCollection 2016.
        http://www.ncbi.nlm.nih.gov/pubmed/26859297
      • Kitamura S.
        Pediatric Coronary Artery Revascularization Surgery: Development and Effects on Survival, Cardiac Events and Graft Patency for Children With Kawasaki Disease Coronary Involvements.
        Iran J Pediatr. 2016 Feb;26(1):e3875. doi: 10.5812/ijp.3875. Epub 2016 Jan 30.
        http://www.ncbi.nlm.nih.gov/pubmed/26848378
      • Sahin S, Adrovic A, Barut K, Kasapcopur O.
        Childhood-onset eosinophilic granulomatosis with polyangiitis: a rare childhood vasculitis mimicking anthrax and eosinophilic leukaemia.
        BMJ Case Rep. 2016 Feb 17;2016. pii: bcr2015213856. doi: 10.1136/bcr-2015-213856.
        http://www.ncbi.nlm.nih.gov/pubmed/26887883
      • Mathew AJ, Goel R, Kumar S, Danda D.
        Childhood-onset Takayasu arteritis: an update.
        Int J Rheum Dis. 2016 Feb;19(2):116-26. doi: 10.1111/1756-185X.12718. Epub 2015 Nov 20.
        http://www.ncbi.nlm.nih.gov/pubmed/26585174
      • Singh-Grewal D, Durkan AM.
        Pediatric Vasculitis.
        Indian J Pediatr. 2016 Feb;83(2):156-62. doi: 10.1007/s12098-015-1876-2. Epub 2015 Sep 14.
        http://www.ncbi.nlm.nih.gov/pubmed/26365154
 
DICIEMBRE 2015
      • Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
        High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.

        PLoS One. 2015 Dec 10;10(12):e0144603. doi: 10.1371/journal.pone.0144603
        http://www.ncbi.nlm.nih.gov/pubmed/26658843
      • Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW.
        Cardiovascular imaging in children and adults following Kawasaki disease.
        Insights Imaging. 2015 Dec;6(6):697-705. doi: 10.1007/s13244-015-0422-0.
        http://www.ncbi.nlm.nih.gov/pubmed/26210915
      • Agarwal S, Mulkutkar S, Suri D, Singh S, Gupta A.
        Retinal Vasculitis in Kawasaki Disease.
        Indian J Pediatr. 2015 Dec;82(12):1183-4. doi: 10.1007/s12098-015-1763-x
        http://www.ncbi.nlm.nih.gov/pubmed/25990595
 
NOVIEMBRE 2015
      • Surjit Singh, Pandiarajan Vignesh, David Burgner
        The epidemiology of Kawasaki disease: a global update

        Arch Dis Child 2015;100:1084-1088 doi:10.1136/archdischild-2014-307536
        [Abstract]
      • Mieko Yamagata, Kei Ikeda, Kenji Tsushima, Ken Iesato, Mitsuhiro Abe, Takashi Ito, Daisuke Kashiwakuma, Shin-ichiro Kagami, Itsuo Iwamoto, Daiki Nakagomi, Takao Sugiyama, Yuichiro Maruyama, Shunsuke Furuta, David Jayne, Takashi Uno, Koichiro Tatsumi and Hiroshi Nakajima
        Prevalence and responsiveness to treatment of lung abnormalities on chest computed tomography in patients with microscopic polyangiitis – a multicenter, longitudinal, retrospective study of 150 hospital-based consecutive Japanese patients

        Arthritis & Rheumatology DOI: 10.1002/art.39475
        Abstract
      • Takuto Takahashi, Hiroshi Sakakibara, Yoshihiko Morikawa, Masaru Miura
        Development of coronary artery lesions in indolent kawasaki disease following initial spontaneous defervescence: a retrospective cohort study

        Pediatric Rheumatology 2015, 13:44 (4 November 2015)
        Abstract
 
OCTUBRE 2015
      • Dietz SM, Tacke CE, Gort J, Kuipers IM, de Groot E, Wiegman A, Hutten BA, Kuijpers TW.
        Carotid Intima-Media Thickness in Patients With a History of Kawasaki Disease.
        Circ J. 2015 Oct 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26439324
      • Hong Y, Eleftheriou D, Klein NJ, Brogan PA.
        Impaired function of endothelial progenitor cells in children with primary systemic vasculitis.
        Arthritis Res Ther. 2015 Oct 16;17(1):292. doi: 10.1186/s13075-015-0810-3.
        http://www.ncbi.nlm.nih.gov/pubmed/26475131
      • Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.
        Cardiovascular status after Kawasaki disease in the UK
        Heart. 2015 Oct 15;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27
        http://www.ncbi.nlm.nih.gov/pubmed/26316045
      • Yesilkaya S, Acikel C, Fidanci BE, Polat A, Sozeri B, Ayaz NA, Makay BB, Simsek D, Akinci N, Özçelik G, Kavukçu S, Emre S, Donmez O, Delibas A, Yüksel S, Berdeli A, Poyrazoglu H, Saldir M, Fidanci K, Çakar N, Peru H, Bakkaloglu S, Tabel Y, Sari O, Aydogan U, Ozenc S, Basbozkurt G, Unsal E, Kasapcopur O, Gok F, Ozen S, Demirkaya E.
        Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children
        Clin Exp Rheumatol. 2015 Sep 22. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26393894
 
SEPTIEMBRE 2015
      • Mohammad AJ, Smith RM, Chow YW, Chaudhry AN, Jayne DRW.
        Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience
        J Rheumatol October 2015 42(10):1906-13; doi:10.3899/jrheum.141344
        http://www.jrheum.org/content/42/10/1906.abstract
      • Felicetti P, Trotta F, Bonetto C, Santuccio C, Pernus YB, Burgner D, Chandler R, Girolomoni G, Hadden RD, Kochar S, Kukucu M, Monaco G, Ozen S, Pahud B, Phuong L, Bachtiar NS, Teeba A, Top K, Varricchio F, Wise RP, Zanoni G, Živkovic S, Bonhoeffer J; Brighton Collaboration Vasculitis Working Group.
        Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
        Vaccine. 2015 Sep 18. pii: S0264-410X(15)01293-1. doi: 10.1016/j.vaccine.2015.09.027. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26392009
      • Mori Y, Katayama H, Kishi K, Ozaki N, Shimizu T, Tamai H.
        Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease.
        J Cardiol. 2015 Sep 14. pii: S0914-5087(15)00265-8. doi: 10.1016/j.jjcc.2015.08.008.  [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26381328
 
AGOSTO 2015
      • Turnier JL, Anderson MS, Heizer HR, Jone PN, Glodé MP, Dominguez SR.
        Concurrent Respiratory Viruses and Kawasaki Disease.
        Pediatrics. 2015 Aug 24. pii: peds.2015-0950. EPUB ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26304824  
      • Tremoulet AH, Dutkowski J, Sato Y, Kanegaye JT, Ling XB, Burns JC.
        Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease.
        Pediatr Res. 2015 Aug 3. doi:10.1038/pr.2015.137. EPUB ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/26237629
 
JULIO 2015
      • Soliman M, Laxer R, Manson D, Yeung R, Doria AS.
        Imaging of systemic vasculitis in childhood.
        Pediatr Radiol. 2015 Jul;45(8):1110-25. doi: 10.1007/s00247-015-3339-3. Epub 2015 Jul 22.
        http://www.ncbi.nlm.nih.gov/pubmed/26198677
 
JUNIO 2015
      • Jones RB, Furuta S, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; European Vasculitis Society (EUVAS).
        Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
        Ann Rheum Dis. 2015 Jun;74(6):1178-82. doi: 10.1136/annrheumdis-2014-206404.
        http://www.ncbi.nlm.nih.gov/pubmed/25739829
      • Qing Ye, Wen-xia Shao, Shi-qiang Shang, Ting Zhang, Jian Hu and Chun-chun Zhang
        A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
        Arthritis Rheumatol. 2015 Jul;67(7):1943-50. doi: 10.1002/art.39112.
        http://www.ncbi.nlm.nih.gov/pubmed/25778686
      • Michele Iudici, Xavier Puéchal, Christian Pagnoux, Pierre Quartier, Christian Agard, Achille Aouba, Matthias Büchler, Ramiro Cevallos, Pascal Cohen, Claire de Moreuil, Philippe Guilpain, Alain Le Quellec, Pascal Roblot, Jacques Serratrice, Claude Bachmeyer, Éric Daugas, Benjamin Terrier, Luc Mouthon, Loïc Guillevin and for the French Vasculitis Study Group
        Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry
        Arthritis Rheumatol. 2015 Jul;67(7):1959-65. doi: 10.1002/art.39122.
        http://www.ncbi.nlm.nih.gov/pubmed/25808634
      • Singh S, Vignesh P, Burgner D.
        The epidemiology of Kawasaki disease: a global update.
        Arch Dis Child. 2015 Jun 25. pii: archdischild-2014-307536. doi: 10.1136/archdischild-2014-307536. [Epub ahead of print] Review.
        http://www.ncbi.nlm.nih.gov/pubmed/26111818
      •  Burns JC, Franco A.
        The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease.
        Expert Rev Clin Immunol. 2015 Jul;11(7):819-25. doi: 10.1586/1744666X.2015.1044980.
        http://www.ncbi.nlm.nih.gov/pubmed/26099344
      • Maddox RA, Holman RC, Uehara R, Callinan LS, Guest JL, Schonberger LB, Nakamura Y, Yashiro M, Belay ED.
        Recurrent Kawasaki disease, United States and Japan.
        Pediatr Int. 2015 Jun 11. doi: 10.1111/ped.12733. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26096590
 
MAYO 2015
 
ABRIL 2015
      • Shulman ST, Rowley AH.
        Kawasaki disease: insights into pathogenesis and approaches to treatment.
        Nat Rev Rheumatol. 2015 Apr 28. doi: 10.1038/nrrheum.2015.54. [Epub ahead of print] Review.
        http://www.ncbi.nlm.nih.gov/pubmed/25907703  
      • Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC.
        Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis

        BMJ Open. 2015 Apr 14;5(4):e006703. doi: 10.1136/bmjopen-2014-006703.
        http://www.ncbi.nlm.nih.gov/pubmed/25872939  
      • Merlin E, Mouy R, Pereira B, Mouthon L, Bourmaud A, Piette JC, Landman-Parker J, Chellun P, Layadi M, Thomas C, Guillevin L, Prieur AM, Quartier P.
        Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa

        Joint Bone Spine. 2015 Apr 14. pii: S1297-319X(15)00025-1. doi: 10.1016/j.jbspin.2015.01.007. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25887252  
      • Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, Flodrops H, Ulinski T, Allain-Launay E, Boyer O, Dunand O, Fischbach M, Hachulla E, Pietrement C, Le Pogamp P, Stephan JL, Belot A, Nivet H, Nobili F, Guillevin L, Quartier P, Deschênes G, Salomon R, Essig M, Harambat J.
        Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study

        Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i104-i112. doi: 10.1093/ndt/gfv011. Epub 2015 Feb 12.
        http://www.ncbi.nlm.nih.gov/pubmed/25676121
 
MARZO 2015
      • Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA
        Predicting IVIG resistance in UK Kawasaki disease
        Arch Dis Child. 2015 Apr;100(4):366-8. doi: 10.1136/archdischild-2014-307397.
        http://www.ncbi.nlm.nih.gov/pubmed/25670405
      • Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.
        Identification of an Association Between Genomic Hypomethylation of FCGR2A and Susceptibility to Kawasaki Disease and Intravenous Immunoglobulin Resistance by DNA Methylation Array.
        Arthritis Rheumatol. 2015 Mar;67(3):828-36. doi: 10.1002/art.38976.
        http://www.ncbi.nlm.nih.gov/pubmed/25470559
      • Ortiz-Sanjuan F, Blanco R, Hernandez JL, Gonzalez-Lopez MA, Loricera J, Lacalle-Calderon M, Pina T, Calvo-Rio V, Alvarez L, Gonzalez-Vela MC, Rueda-Gotor J, Gonzalez-Gay MA.
        Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch-Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis.
        Clin Exp Rheumatol. 2015 Feb 9. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/25665133
 
FEBRERO 2015
      • Avcu G, Sensoy G, Çeliksoy MH, Sogut A, Kefeli M, Karli A, Belet N.
        Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.
        Pediatr Int. 2015 Feb;57(1):155-7.
        http://www.ncbi.nlm.nih.gov/pubmed/25711253
      • Gülhan B, Orhan D, Kale G, Besbas N, Özen S.
        Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura).
        Pediatr Nephrol. 2015 Feb 4.
        http://www.ncbi.nlm.nih.gov/pubmed/25648880
      • Jorquera H, Borzutzky A, Hoyos-Bachiloglu R, García A.
        Association of Kawasaki disease with tropospheric winds in Central Chile: Is wind-borne desert dust a risk factor?
        Environ Int. 2015 Mar 2;78C:32-38.
        http://www.ncbi.nlm.nih.gov/pubmed/25743034
      • Goo HW.
        Coronary Artery Imaging in Children.
        Korean J Radiol. 2015 Mar-Apr;16(2):239-250.
        http://www.ncbi.nlm.nih.gov/pubmed/25741188
      • García Munitis P, Ves Losada J, Montali C.
        Acute abdomen at onset of incomplete and atypical Kawasaki disease: Case report.
        Arch Argent Pediatr. 2015 Apr 1;113(2):e88-93.
        http://www.ncbi.nlm.nih.gov/pubmed/25727840
 
DICIEMBRE 2014
      • Aldemir-Kocabaş B, Kcal MM, Ramoğlu MG, Tutar E, Fitöz S, Çiftçi E, İnce E.
        Recurrent kawasaki disease in a child with retropharyngeal involvement: a case report and literature review.
        Medicine (Baltimore). 2014 Dec;93(29):e139.
        http://www.ncbi.nlm.nih.gov/pubmed/25546657
      • Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
        N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
        Cardiol Young. 2014 Dec 29:1-8.
        http://www.ncbi.nlm.nih.gov/pubmed/25544036
      • Pietraforte D, Gambardella L, Marchesi A, de Jacobis IT, Viora M, Del Principe D, Villani A, Malorni W, Straface E.
        Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: A case report.
        Int J Cardiol. 2014 Dec 13;181C:311-313.
        http://www.ncbi.nlm.nih.gov/pubmed/25540846
      • Uysal F, Bostan OM, Celebi S, Uysal B, Hamitoglu S, Cil E.
        Outcomes of Kawasaki Disease: A Single-Center Experience.
        Clin Pediatr (Phila). 2014 Dec 3. pii: 0009922814561594. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25475592
      • Başaran O, Cakar N, Uncu N, Celikel BA, Kara A, Cayci FS, Taktak A, Gür G.
        Plasma exchange therapy for severe gastrointestinal involvement of Henoch Schönlein purpura in children.
        Clin Exp Rheumatol. 2014 Dec 1. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25436762
      • Eleftheriou D, Batu ED, Ozen S, Brogan PA.
        Vasculitis in children.
        Nephrol Dial Transplant. 2014 Dec 30. pii: gfu393. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25550447
      • Borroni G1, Grassi S, Carugno A.
        Vasculitides with cutaneous expression in children: clinic-pathologic correlations.
        G Ital Dermatol Venereol. 2014 Dec 17. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25516220
      • Bas A, Samanci C, Numan F.
        Percutaneous transcatheter embolization of gastrointestinal bleeding in a child with polyarteritis nodosa.
        Pol J Radiol. 2014 Dec 11;79:465-6.
        http://www.ncbi.nlm.nih.gov/pubmed/25512765
      • López-Mejías R, Genre F, Pérez BS, Castañeda S, Ortego-Centeno N, Llorca J, Ubilla B, Remuzgo-Martínez S, Mijares V, Pina T, Calvo-Río V, Márquez A, Sala-Icardo L, Miranda-Filloy JA, Conde-Jaldón M, Ortiz-Fernández L, Rubio E, León Luque M, Blanco-Madrigal JM, Galíndez-Aguirregoikoa E, González-Vela MC, Ocejo-Vinyals JG, González Escribano F, Martín J, Blanco R, González-Gay MA
        HLA-DRB1 association with Henoch-Schonlein purpura.
        Arthritis Rheumatol. 2014 Dec 2. doi: 10.1002/art.38979. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25470797
      • Kuo HC, Chang JC, Kuo HC, Yu HR, Wang CL, Lee CP, Huang LT, Yang KD.
        DNA methylation array identifies genomic hypomethylation of FCGR2A in the susceptibility of Kawasaki disease and intravenous immunoglobulin resistance.
        Arthritis Rheumatol. 2014 Dec 2. doi: 10.1002/art.38976. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25470559
 
NOVIEMBRE 2014
      • Maric LS, Knezovic I, Papic N, Mise B, Roglic S, Markovinovic L, Tesovic G.
        Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
        Rheumatol Int. 2014 Nov 28. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/?term=25429794
      • Ni FF, Li CR, Li Q, Xia Y, Wang GB, Yang J.
        Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.
        Clin Exp Immunol. 2014 Nov;178(2):384-93.
        http://www.ncbi.nlm.nih.gov/pubmed/?term=25039241
      • Li X, Liang S, Zheng C, Zeng C, Zhang H, Hu W, Liu Z.
        Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.
        Pediatr Nephrol. 2014 Dec;29(12):2365-71.
        http://www.ncbi.nlm.nih.gov/pubmed/?term=25027576
      • Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, Takeuchi M.
        Neonatal Kawasaki disease: case report and data from nationwide survey in Japan.
        Eur J Pediatr. 2014 Nov;173(11):1533-6.
        http://www.ncbi.nlm.nih.gov/pubmed/?term=24889336
      • Lin YJ, Lan YC, Lai CH, Lin TH, Huang SM, Liao CC, Lin CW, Hung CH, Tien N, Liu X, Chien WK, Chen JH, Tsai FJ.
        Association of promoter genetic variants in interleukin-10 and kawasaki disease with coronary artery aneurysms.
        J Clin Lab Anal. 2014 Nov;28(6):461-4.
        http://www.ncbi.nlm.nih.gov/pubmed/?term=24659220
 
OCTUBRE 2014
      • Teng X, Wang Y, Lin N, Sun M, Wu J.
        Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.
        Clin Rheumatol. 2014 Oct 3. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/25273597 
      • Johnson EF, Lehman JS, Wetter DA, Lohse CM, Tollefson MM.
        Henoch-Schonlein purpura and systemic disease in children: Retrospective study of clinical findings, histopathology, and direct immunofluorescence in 34 pediatric patients.
        Br J Dermatol. 2014 Oct 11. doi: 10.1111/bjd.13472. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/25308217 
      • Salah S, Rizk S, Lotfy HM, El Houchi S, Marzouk H, Farag Y.
        MEFV gene mutations in Egyptian children with Henoch-Schonlein purpura.
        Pediatr Rheumatol Online J. 2014 Sep 9;12:41. doi: 10.1186/1546-0096-12-41. eCollection 2014.
        http://www.ncbi.nlm.nih.gov/pubmed/25232290 
      • Han BK, Lesser A, Rosenthal K, Dummer K, Grant K, Newell M.
        Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease.
        Am J Cardiol. 2014 Sep 16. pii: S0002-9149(14)01776-7. doi: 10.1016/j.
        http://www.ncbi.nlm.nih.gov/pubmed/25307199 
      • Özlem Bağ, Utku Karaarslan, Çiğdem Ecevit, Gül İrem Kanberoğlu, Aysel Öztürk
        The Value of Platelet Indices in Henoch- Schonlein Purpura
        Ann Paediatr Rheum. 2014; 3(3): 126- 131
        http://www.scopemed.org/?mno=154884
      • Zhang PP1, Li YT, Li XF, Pan L, Chen ZG.
        Clinical research on serum lipid changes in children with Kawasaki disease and its relationship with coronary artery lesions.
        Clin Exp Rheumatol. 2014 Sep 19. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25237009
      • Ruby Haviv, Maya Capua, Jacob Amir and Liora Harel
        Cutaneous polyarteritis nodosa successfully treated with topical diflucortolone valerate – a case report & review of the literatura.
        Pediatric Rheumatology 2014, 12:46  doi:10.1186/1546-0096-12-46
        http://www.ped-rheum.com/content/12/1/46
 
SEPTIEMBRE 2014
      • JCS Joint Working Group
        Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013).
        Circ J. 2014 Sep 25;78(10):2521-2562. Epub 2014 Sep 22.
        http://www.ncbi.nlm.nih.gov/pubmed/25241888
      • Moffett BS, Syblik D, Denfield S, Altman C, Tejtel-Sexson K.
        Epidemiology of Immunoglobulin Resistant Kawasaki Disease: Results from a Large, National Database.
        Pediatr Cardiol. 2014 Sep 2. [Epub ahead of print].
        http://www.ncbi.nlm.nih.gov/pubmed/25179461
      • Lally L, Lebovics RS, Huang WT, Spiera RF.
        Effectiveness of Rituximab for the otolaryngologic manifestations of Granulomatosis With Polyangiitis (Wegener’s).
        Arthritis Care Res (Hoboken) 2014 Sep;66(9):1403-1409.
        http://onlinelibrary.wiley.com/doi/10.1002/acr.22311/abstract
 
AGOSTO 2014
      • Comarmond C, Cacoub P.
        Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment.
        Autoimmun Rev. 2014 Aug 20. pii: S1568-9972(14)00161-X. doi: 10.1016/j.autrev.2014.08.017. [Epub ahead of print]
        http://www.ncbi.nlm.nih.gov/pubmed/25149391
      • Guillevin L
        Treatment of severe and/or refractory ANCA-associated vasculitis.
        Curr Rheumatol Rep. 2014 Aug;16(8):430. doi: 10.1007/s11926-014-0430-y.
        http://www.ncbi.nlm.nih.gov/pubmed/24925586
      • Smith KA1, Yunker WK2.
        Kawasaki disease is associated with sensorineural hearing loss: A systematic review.
        Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1216-1220.
        http://www.ncbi.nlm.nih.gov/pubmed/24951399
      • Sun L1, Wang H2, Jiang X1, Mo Y2, Yue Z2, Huang L2, Liu T2.
        Clinical and pathological features of microscopic polyangiitis in 20 children.
        J Rheumatol. 2014 Aug;41(8):1712-9.
        http://www.ncbi.nlm.nih.gov/pubmed/24986845
      • Moore A, Harnden A, Mayon-White R.
        Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.
        Br J Gen Pract. 2014 Aug;64(625):e477-83.
        http://www.ncbi.nlm.nih.gov/pubmed/25071060
 
JULIO 2014
      • Davin JC, Coppo R.
        Henoch-Schönlein purpura nephritis in children.
        Nat Rev Nephrol. 2014 Jul 29. doi: 10.1038/nrneph.2014.126. [Epub ahead of print].
        http://www.ncbi.nlm.nih.gov/pubmed/25072122
      • Xing Y1, Wang H, Liu X, Yu X, Chen R, Wang C, Yu X, Sun L.
        Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.
        Mol Biol Rep. 2014 Jul 3.
        http://www.ncbi.nlm.nih.gov/pubmed/24990693
      • Zhao JM1, Wang XH.
        Clinical significance of anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies in children with Kawasaki disease.
        Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jul;16(7):740-4.
        http://www.ncbi.nlm.nih.gov/pubmed/25008884
      • Li X1, Liang S, Zheng C, Zeng C, Zhang H, Hu W, Liu Z.
        Clinicopathological characteristics and outcomes of pediatric patients with systemic small blood vessel vasculitis.
        Pediatr Nephrol. 2014 Jul 16.
        http://www.ncbi.nlm.nih.gov/pubmed/25027576
      • Ni FF1, Li CR, Li Q, Xia Y, Wang GB, Yang J.
        Regulatory T-cell microRNA expression changes in children with acute Kawasaki disease.
        Clin Exp Immunol. 2014 Jul 16.
        http://www.ncbi.nlm.nih.gov/pubmed/25039241
      • Shafferman A1, Birmingham JD2, Cron RQ3.
        High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report.
        Pediatr Rheumatol Online J. 2014 Jul 11;12:26.
        http://www.ncbi.nlm.nih.gov/pubmed/25045337
      • Puhakka L1, Saat R2, Klockars T3, Kajosaari L3, Salo E4, Nieminen T4.
        Retropharyngeal involvement in Kawasaki disease-A report of four patients with retropharyngeal edema verified by magnetic resonance imaging.
        Int J Pediatr Otorhinolaryngol. 2014 Jul 12.
        http://www.ncbi.nlm.nih.gov/pubmed/25081603
      • Fujimaru T1, Ito S2, Masuda H3, Oana S3, Kamei K1, Ishiguro A3, Kato H4, Abe J5.
        Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
        Cytokine. 2014 Jul 28. pii: S1043-4666(14)00213-0.
        http://www.ncbi.nlm.nih.gov/pubmed/25082649
 
JUNIO 2014
      • Dimitriades VR, Brown AG,Gedalia A.
        Kawasaki disease: pathophysiology, clinical manifestations, and management
        Curr Rheumatol Rep. 2014 Jun;16(6):423.
        http://www.ncbi.nlm.nih.gov/pubmed/24744086
      • Szugye HS1, Zeft AS2, Spalding SJ3.
        Takayasu Arteritis in the pediatric population: a contemporary United States-Based Single Center Cohort.
        Pediatr Rheumatol Online J. 2014 Jun 4;12:21. doi: 10.1186/1546-0096-12-21. eCollection 2014.
        http://www.ncbi.nlm.nih.gov/pubmed/24955077
      • Smith KA1, Yunker WK2.
        Kawasaki disease is associated with sensorineural hearing loss: A systematic review.
        Int J Pediatr Otorhinolaryngol. 2014 Jun 2. pii: S0165-5876(14)00294-8. doi: 10.1016/j.ijporl.2014.05.026. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24951399
      • Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, Takeuchi M.
        Neonatal Kawasaki disease: case report and data from nationwide survey in Japan.
        Eur J Pediatr. 2014 Jun 3. [Epub ahead of print]
      • Rodó X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, Lipkin WI, Williams BL, Couto-Rodriguez M, Nakamura Y, Uehara R, Tanimoto H, Morguí JA.
        Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan.
        Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):7952-7957.
      • Dimitriades VR1, Brown AG, Gedalia A.
        Kawasaki disease: pathophysiology, clinical manifestations, and management.
        Curr Rheumatol Rep. 2014 Jun;16(6):423. doi: 10.1007/s11926-014-0423-x.
        http://www.ncbi.nlm.nih.gov/pubmed/24744086
      • Stagi S1, Bertini F2, Rigante D3, Falcini F2.
        Vitamin D levels and effects of vitamin D replacement in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.
        Int J Pediatr Otorhinolaryngol. 2014 Jun;78(6):964-8. doi: 10.1016/j.ijporl.2014.03.026. Epub 2014 Apr 1.
        http://www.ncbi.nlm.nih.gov/pubmed/24746456
 
MAYO 2014
      • Bohm M, Gonzalez Fernandez MI, Ozen S, Pistorio A, Dolezalova P, Brogan P, Barbano G, Sengler C, Klein-Gitelman M, Quartier P, Fasth A, Herlin T, Terreri MT, Nielsen S, van Rossum MA, Avcin T, Castell ER, Foeldvari I, Foell D, Kondi A, Koné-Paut I, Kuester RM, Michels H, Wulffraat N, Amer HB, Malattia C, Martini A, Ruperto N.
        Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis).
        Pediatr Rheumatol Online J. 2014 May 26;12:18. doi: 10.1186/1546-0096-12-18. eCollection 2014.
      • Tremoulet AH, Jain S, Jaggi P, et al.
        Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
        Lancet. 2014 May 17;383 (9930):1731-8.
      • Scuccimarri R1, Yeung RS2.
        Kawasaki disease: High index of suspicion needed in a febrile child.
        Paediatr Child Health. 2014 May;19(5):239-40.
        http://www.ncbi.nlm.nih.gov/pubmed/24855425
      • D'Alessandro M1, Buoncompagni A, Minoia F, Coccia MC, Martini A, Picco P.
        Cytomegalovirus-related necrotising vasculitis mimicking Henoch-Schönlein syndrome.
        Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):73-5. Epub 2014 May 16.
        http://www.ncbi.nlm.nih.gov/pubmed/24854375
      • Fujino M1, Hata T, Kuriki M, Horio K, Uchida H, Eryu Y, Boda H, Miyata M, Yoshikawa T.
        Inflammation Aggravates Heterogeneity of Ventricular Repolarization in Children With Kawasaki Disease.
        Pediatr Cardiol. 2014 May 14. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24823886
 
ABRIL 2014
 
MARZO 2014
      • Cellucci T1, Tyrrell PN, Twilt M, Sheikh S, Benseler SM.
        Distinct phenotype clusters in childhood inflammatory brain diseases: implications for diagnostic evaluation.
        Arthritis Rheumatol. 2014 Mar;66(3):750-6. doi: 10.1002/art.38274.
        http://www.ncbi.nlm.nih.gov/pubmed/24574236
      • Zhou Q1, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A,Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CC, Wood GM, Ling A, Kelly SJ, Kleiner DE, MullikinJC,Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA,Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I.
        Early-onset stroke and vasculopathy associated with mutations in ADA2.
        N Engl J Med. 2014 Mar 6;370(10):911-20. doi: 10.1056/NEJMoa1307361. Epub 2014 Feb 19.
        http://www.ncbi.nlm.nih.gov/pubmed/24552284
      • NavonElkan P1, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E,Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, ShohatM,Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E.
        Mutant adenosine deaminase 2 in a polyarteritisnodosa vasculopathy.
        N Engl J Med. 2014 Mar 6;370(10):921-31. doi: 10.1056/NEJMoa1307362. Epub 2014 Feb 19.
        http://www.ncbi.nlm.nih.gov/pubmed/24552285
      • Pietraforte D, Gambardella L, Marchesi A, Tarissi de Jacobis I, Villani A, Del Principe D, Malorni W, Straface E.
        Platelets in Kawasaki patients: Two different populations with different mitochondrial functions.
        Int J Cardiol. 2014 Mar 15;172(2):526-8. doi: 10.1016/j.ijcard.2014.01.022. Epub 2014 Jan 22.
        http://www.ncbi.nlm.nih.gov/pubmed/24491862
      • Kwak JH, Song J, Kang IS, Huh J, Lee HJ.
        Changes in coronary perfusion after occlusion of coronary arteries in kawasaki disease.
        Yonsei Med J. 2014 Mar 1;55(2):353-9. doi: 10.3349/ymj.2014.55.2.353.
        http://www.ncbi.nlm.nih.gov/pubmed/24532503
      • Kawasaki T, Naoe S.
        History of Kawasaki disease.
        Clin Exp Nephrol. 2014 Mar 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24595558
      • Talukder MK, Islam MI, Rahman SA.
        Clinical and laboratory profile of childhood polyarteritis nodosa in a Bangladeshi tertiary hospital.
        Int J Rheum Dis. 2014 Mar 6. doi: 10.1111/1756-185X.12319. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24597834
      • van Oers HA, Tacke CE, Haverman L, Kuipers IM, Maurice-Stam H, Kuijpers TW, Grootenhuis MA.
        Health Related Quality of Life and Perceptions of Child Vulnerability among parents of children with a history of Kawasaki Disease.
        Acta Paediatr. 2014 Mar 3. doi: 10.1111/apa.12619. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24588557
 
FEBRERO 2014
      • Durmaz B, Aykut A, Hursitoglu G, Bak M, Serdaroglu E, Onay H, Ozkinay F.
        Association of mannose binding lectin codon 54 polymorphism with predisposition to Henoch-Schönlein purpura in childhood.
        Int J Rheum Dis. 2014 Feb 28. doi: 10.1111/1756-185X.12321. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24576294
      • Rheumatol Int. 2014 Feb 23. [Epub ahead of print] Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.
        Masarweh K, Horovitz Y, Avital A, Spiegel R.
        http://www.ncbi.nlm.nih.gov/pubmed/24563020
      • Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB.
        Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura.
        J Korean Med Sci. 2014 Feb;29(2):198-203. doi: 10.3346/jkms.2014.29.2.198. Epub 2014 Jan 28.
        http://www.ncbi.nlm.nih.gov/pubmed/24550645
      • López-Mejías R, Sevilla Pérez B, Genre F, Castañeda S, Ortego-Centeno N, Miranda-Filloy JA, Llorca J, Martín J, Blanco R, González-Gay MA.
        Lack of association between IL6 gene and Henoch-Schönlein purpura.
        Clin Exp Rheumatol. 2014 Feb 11. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24528956
      • Luca CM, Laicini EA, Fossali EF.
        Eosinophil cationic protein in Henoch-Schönlein purpura.
        World J Pediatr. 2014 Feb;10(1):90-1. doi: 10.1007/s12519-014-0462-4.
        http://www.ncbi.nlm.nih.gov/pubmed/24464674
      • Suthar R, Singh S, Bhalla AK, Attri SV.
        Pattern of subcutaneous fat during follow-up of a cohort of North Indian children with Kawasaki disease: a preliminary study.
        Int J Rheum Dis. 2014 Feb 11. doi: 10.1111/1756-185X.12296. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24517191
      • Tamaki W, Tsuda E, Takehiro I, Tanaka N, Fujieda M.
        Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients afterKawasaki disease: a right parasternal approach.
        Heart Vessels. 2014 Feb 9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24510254
      • Hwang B.
        Epidemiology of Kawasaki Disease.
        Pediatr Neonatol. 2014 Feb 6. pii: S1875-9572(13)00222-2. doi: 10.1016/j.pedneo.2013.10.008. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24508358
      • Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, Cheng AL, Lee WL, Hu JJ, Yeh SJ, Chang CC, Chiang BL, Wu MH, Huang LM.
        Viral infections associated with Kawasaki disease.
        J Formos Med Assoc. 2014 Feb 1. pii: S0929-6646(14)00003-5. doi: 10.1016/j.jfma.2013.12.008. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24495555
      • Sci Rep. 2014 Feb 28;4:4247. doi: 10.1038/srep04247.
        8p22-23-rs2254546 as a Susceptibility Locus for Kawasaki Disease: a Case-control Study and a Meta-analysis.
        Wang W, Lou J, Lu XZ, Qi YQ, Shen N, Zhong R, Wang YJ, Zou L, Zhang Q, Duan JY, Ke JT, Miao XP, Gong FQ.
        http://www.ncbi.nlm.nih.gov/pubmed/24577620
      • Levin M, Burgner D.
        Treatment of Kawasaki disease with anti-TNF antibodies.
        Lancet. 2014 Feb 21. pii: S0140-6736(14)60131-8. doi: 10.1016/S0140-6736(14)60131-8. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24572998
      • S M, Singh S, Suri D, Gupta A, Gupta A.
        Acute Anterior Uveitis as the Presenting Feature of Kawasaki Disease.
        Indian J Pediatr. 2014 Feb 25. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24562721
      • Sonoda K, Mori M, Hokosaki T, Yokota S.
        Infliximab Plus Plasma Exchange Rescue Therapy in Kawasaki Disease.
        J Pediatr. 2014 Feb 19. pii: S0022-3476(14)00026-2. doi: 10.1016/j.jpeds.2014.01.020. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24560183
      • Yi DY, Kim JY, Choi EY, Choi JY, Yang HR.
        Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.
        BMC Pediatr. 2014 Feb 18;14(1):51. doi: 10.1186/1471-2431-14-51.
        http://www.ncbi.nlm.nih.gov/pubmed/24548331
      • Durmaz B, Aykut A, Hursitoglu G, Bak M, Serdaroglu E, Onay H, Ozkinay F.
        Association of mannose binding lectin codon 54 polymorphism with predisposition to Henoch-Schönlein purpura in childhood.
        Int J Rheum Dis. 2014 Feb 28. doi: 10.1111/1756-185X.12321. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24576294
      • Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
        Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
        Lancet. 2014 Feb 21. pii: S0140-6736(13)62298-9. doi: 10.1016/S0140-6736(13)62298-9. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24572997
      • Duan C, Du ZD, Wang Y, Jia LQ.
        Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease.
        World J Pediatr. 2014 Mar 6. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/24599612
      • Awaya A, Nishimura C.
        A Combination of Cross Correlation and Trend Analyses Reveals that Kawasaki Disease is a Pollen-Induced Delayed-Type Hyper-Sensitivity Disease.
        Int J Environ Res Public Health. 2014 Mar 4;11(3):2628-41. doi: 10.3390/ijerph110302628.
        http://www.ncbi.nlm.nih.gov/pubmed/24599039
      • Holve TJ, Patel A, Chau Q, Marks AR, Meadows A, Zaroff JG.
        Long-term Cardiovascular Outcomes in Survivors of Kawasaki Disease.
        Pediatrics. 2014 Feb;133(2):e305-11. doi: 10.1542/peds.2013-1638. Epub 2014 Jan 20.
        http://www.ncbi.nlm.nih.gov/pubmed/24446449
ENERO 2014
      • Tacke CE, Breunis WB, Pereira RR, Breur JM, Kuipers IM, Kuijpers TW.
        Five Years of Kawasaki Disease in the Netherlands: A National Surveillance Study.
        Pediatr Infect Dis J. 2014 Jan 23. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/24463809
      • Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA.
        Management of Kawasaki disease.
        Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841.
        http://www.ncbi.nlm.nih.gov/pubmed/24162006
 
OCTUBRE 2013
      • Trnka P.
        Henoch-Schönlein purpura in children.
        J Paediatr Child Health. 2013 Oct 18.
        http://www.ncbi.nlm.nih.gov/pubmed/24134307
      • Mondal R, Sarkar S, Pal P, Nandi M, Hazra A, Sabui TK.
        Childhood Polyarteritis Nodosa: A Prospective Multicentre Study from Eastern India.
        Indian J Pediatr. 2013 Oct 10.
        http://www.ncbi.nlm.nih.gov/pubmed/24113882
      • Bayers S, Shulman ST, Paller AS.
        Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
        J Am Acad Dermatol. 2013 Oct;69(4):501.
        http://www.ncbi.nlm.nih.gov/pubmed/24034379
      • Bayers S, Shulman ST, Paller AS.
        Kawasaki disease: part II. Complications and treatment.
        J Am Acad Dermatol. 2013 Oct;69(4):513.
        http://www.ncbi.nlm.nih.gov/pubmed/24034380
      • Rhim JW, Youn YS, Han JW, Lee SJ, Oh JH, Lee KY.
        Changes in Kawasaki Disease during Two Decades at a Single Institution in Daejeon, Korea.
        Pediatr Infect Dis J. 2013 Oct 18.
        http://www.ncbi.nlm.nih.gov/pubmed/24145172
      • Noto N, Kamiyama H, Karasawa K, Ayusawa M, Sumitomo N, Okada T, Takahashi S.
        Long-term prognostic impact of dobutamine stress echocardiography in patients with Kawasaki disease and coronary artery lesions: A 15-year follow-up study.
        J Am Coll Cardiol. 2013 Oct 1. pii: S0735-1097(13)05454-5.
        http://www.ncbi.nlm.nih.gov/pubmed/24140657
      • Lue HC, Chen LR, Lin MT, Chang LY, Wang JK, Lee CY, Wu MH.
        Epidemiological Features of Kawasaki Disease in Taiwan, 1976-2007: Results of Five Nationwide Questionnaire Hospital Surveys.
        Pediatr Neonatol. 2013 Oct 10.
        http://www.ncbi.nlm.nih.gov/pubmed/24120536
      • Hoyer PF.
        Prevention of renal disease inHenoch-Schonlein purpura: clear evidence against steroids.
        Arch Dis Child. 2013 Oct;98(10):750-1.
        http://www.ncbi.nlm.nih.gov/pubmed/23868916
      • Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J.
        Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).
        Arch Dis Child. 2013 Oct;98(10):756-63
        http://www.ncbi.nlm.nih.gov/pubmed/23845696
 
SEPTIEMBRE 2013
      • Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Choi JY, Song R, Kang YM, Kang SW, Baek HJ, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczyk E, Lee EY, Song YW, Ohno S, Lee EB.
        Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease.
        Ann Rheum Dis. 2013 Sep 1;72(9):1510-6. doi: 10.1136/annrheumdis-2011-200288.
        http://www.ncbi.nlm.nih.gov/pubmed/23041938
      • Dolezalova P, Price-Kuehne FE, Ozen S, Benseler SM, Cabral DA, Anton J, Brunner J, Cimaz R, O'Neil KM, Wallace CA, Wilkinson N, Eleftheriou D, Demirkaya E, Böhm M, Krol P, Luqmani RA, Brogan PA.
        Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS).
        Ann Rheum Dis. 2013 Oct 1;72(10):1628-33. doi: 10.1136/annrheumdis-2012-202111.
        http://www.ncbi.nlm.nih.gov/pubmed/23100606
      • Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, Klein NJ, Brogan PA.
        Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years.
        Arthritis Rheum. 2013 Sep;65(9):2476-85. doi: 10.1002/art.38024.
        http://www.ncbi.nlm.nih.gov/pubmed/23754739
 
AGOSTO 2013
      • Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
        Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease.
        J Pediatr. 2013 Aug;163(2):521-526.e1. doi: 10.1016/j.jpeds.2013.01.022. Epub 2013 Feb 26.
        http://www.ncbi.nlm.nih.gov/pubmed/23485027
 
JUNIO 2013
      • Gendelman S, Zeft A, Spalding SJ.
        Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort.
        J Rheumatol. 2013 Jun;40(6):929-35. doi: 10.3899/jrheum.120808. Epub 2013 May 1.
        http://www.ncbi.nlm.nih.gov/pubmed/23637321
 
MAYO 2013
 
MARZO 2013
      • Ben Ameur S, Niaudet P, Baudouin V, Bourgeois ML, Houdouin V, Delacourt C, Hadchouel A.
        Lung manifestations in MPO-ANCA associated vasculitides in children.
        Pediatr Pulmonol. 2013 Mar 26. doi: 10.1002/ppul.22793. [Epub ahead of print]http://www.ncbi.nlm.nih.gov/pubmed/23532899
      • Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
        Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
        Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.
        http://www.ncbi.nlm.nih.gov/pubmed/23440694
 
FEBRERO 2013
      • Lega JC, Bozio A, Cimaz R, Veyrier M, Floret D, Ducreux C, Reix P, Di Filippo S.
        Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease.
        Arch Dis Child. 2013 Feb;98(2):97-102. doi: 10.1136/archdischild-2011-301256. Epub 2012 Dec 12.
        http://www.ncbi.nlm.nih.gov/pubmed/23235890
 
ENERO 2013
      • Ling XB, Kanegaye JT, Ji J, Peng S, Sato Y, Tremoulet A, Burns JC,Cohen HJ.
        Point-of-care differentiation of Kawasaki disease from other febrile illnesses.
        J Pediatr. 2013 Jan;162:183-8.e3. doi: 10.1016/j.jpeds.2012.06.012. Epub 2012 Jul 20.
        http://www.ncbi.nlm.nih.gov/pubmed/22819274
      • Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N,Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA.
        2012 revised international chapel hill consensus conference nomenclature of vasculitides.
        Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.
        http://onlinelibrary.wiley.com/doi/10.1002/art.37715/pdf
 
DICIEMBRE 2012
    • Splendiani A, Catalucci A, Limbucci N, Turner M, Krings T, Gallucci M.
      Pediatric Inflammatory Diseases. Part III: Small Vessels Vasculitis.
      Neuroradiol J. 2012 Dec 20;25(6):715-24.
      http://www.ncbi.nlm.nih.gov/pubmed/24029185
PATROCINADORES

Área de Socios